SEC Form 4 · accession 0001654954-18-013254
CorMedix Inc. · CRMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Myron Kaplan
Director
Period of report
Nov 23, 2018
Accepted (ET)
Nov 27, 2018 · 4:19 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001410098
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Nov 23, 2018 | P | 50,000 | $1.2959 | A | 371,166 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy Common Stock)F2 | $0.57 | holding | — | — | — | — | Feb 16, 2028 | Common Stock | 40,000 | 40,000 | D |
| Stock Option (Right to Buy Common Stock)F3 | $2.24 | holding | — | — | — | — | Feb 21, 2027 | Common Stock | 40,000 | 40,000 | D |
| Stock Option (Right to Buy Common Stock)F4 | $4.28 | holding | — | — | — | — | Apr 28, 2026 | Common Stock | 50,000 | 50,000 | D |
Explanation of responses
- F1Represents the weighted average purchase price of the shares purchased ranging from a low of $1.2775 to a high of $1.30 per share.
- F2These options were granted on 2/16/2018. The options vest in full on the first anniversary of the date of grant, subject to continued service on the board.
- F3These options were granted on 2/21/2017. The options vest in full on the first anniversary of the date of grant, subject to continued service on the board.
- F4These options were granted on 4/28/2016. These options shall vest as follows: 1/3 on 4/28/2016, 1/3 on 4/28/2017, and 1/3 on 4/28/2018.